VC-backed Deciphera Pharmaceuticals debuts IPO

Waltham, Massachusetts-based Deciphera Pharmaceuticals, an biotechnology company focused on key mechanisms of tumor drug resistance, has raised $127.5 million for its IPO after pricing its 7.5 million shares at $17 per share. The stock began trading Thursday September 28, 2017 on the NASDAQ under the ticker symbol "DCPH." J.P. Morgan and Piper Jaffray & Co are the lead underwriters. Deciphera's backers include SV Life Sciences and New Leaf Venture Partners.

North AmericaUSBriefs